The relationship between chronic kidney disease and denosumab-induced hypocalcemia in high-age osteoporotic patients
ConclusionAdvanced age combined with low eGFR and low serum Ca status appear to be associated with the incidence of hypocalcemia when using denosumab for the treatment of osteoporosis.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research
More News: Calcium | Chronic Kidney Disease | Drugs & Pharmacology | Orthopaedics | Osteoporosis | Study | Urology & Nephrology | Xgeva